glp-1 obesity drug news october 21 2025 The FDA approved a new pill for weight loss from Eli Lilly on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' @DrLaPook has more on the new medication Companies seek a second obesity

But if you are focused on long-term weight loss, long-term cost, and long-term control, gastric sleeve surgery is often the better strategy

3.1.2.5 SIRT5 SIRT5 is a pivotal enzyme that promotes metabolic homeostasis, inhibiting mitochondrial fission and degradation processes, reducing the susceptibility of the mitochondria to oxidative stress-induced mitochondrial dysfunction

doi:10.1038/nrg3182

Compounding pharmacies prepare micronized progesterone in capsules, topical creams, vaginal inserts, and sublingual troches at custom dosestypically 25 mg to 400 mgallowing prescribers to match the dose to the clinical scenario rather than the pharmacy shelf